Nordea Investment Management AB Acquires New Holdings in Oscar Health, Inc. (NYSE:OSCR)

Nordea Investment Management AB bought a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 78,780 shares of the company's stock, valued at approximately $1,056,000.

Several other hedge funds have also recently made changes to their positions in the stock. Principal Financial Group Inc. boosted its position in shares of Oscar Health by 40.8% in the second quarter. Principal Financial Group Inc. now owns 26,266 shares of the company's stock worth $416,000 after purchasing an additional 7,616 shares during the period. Rhumbline Advisers increased its stake in Oscar Health by 8.7% in the 2nd quarter. Rhumbline Advisers now owns 270,341 shares of the company's stock worth $4,277,000 after buying an additional 21,717 shares in the last quarter. Victory Capital Management Inc. raised its holdings in Oscar Health by 114.1% during the second quarter. Victory Capital Management Inc. now owns 40,976 shares of the company's stock valued at $648,000 after acquiring an additional 21,840 shares during the period. Arizona State Retirement System lifted its position in shares of Oscar Health by 3.7% in the second quarter. Arizona State Retirement System now owns 38,059 shares of the company's stock valued at $602,000 after acquiring an additional 1,351 shares in the last quarter. Finally, Quest Partners LLC bought a new position in shares of Oscar Health in the second quarter worth about $93,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

Shares of NYSE:OSCR traded up $0.08 on Monday, hitting $14.26. 274,366 shares of the company were exchanged, compared to its average volume of 3,016,190. The stock's 50 day moving average price is $15.10 and its 200 day moving average price is $16.88. Oscar Health, Inc. has a 1-year low of $10.45 and a 1-year high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $3.53 billion, a P/E ratio of -237.63 and a beta of 1.70.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm's revenue was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.29) EPS. Sell-side analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Insider Activity at Oscar Health

In other news, Vice Chairman Joshua Kushner bought 276,040 shares of Oscar Health stock in a transaction on Monday, November 11th. The stock was acquired at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the acquisition, the insider now directly owns 5,031,262 shares of the company's stock, valued at $68,324,537.96. The trade was a 5.80 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mario Schlosser sold 6,516 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the transaction, the insider now directly owns 81,962 shares of the company's stock, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders acquired 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OSCR. UBS Group started coverage on Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price on the stock. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Finally, Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and cut their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.